Metrics to compare | 4167 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4167PeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.5x | 9.4x | −0.4x | |
PEG Ratio | −0.53 | 14.10 | 0.00 | |
Price/Book | 1.8x | 2.4x | 2.6x | |
Price / LTM Sales | 5.5x | 5.1x | 3.0x | |
Upside (Analyst Target) | - | 2.6% | 57.2% | |
Fair Value Upside | Unlock | −1.8% | 9.6% | Unlock |
Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally. The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms. It also provides medicine manufacturer technology and services. In addition, the company sells antibacterial raw materials and injectables. Savior Lifetec Corporation was founded in 1993 and is headquartered in Tainan City, Taiwan.